A Study of DM002 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Ovarian NeoplasmsProstatic NeoplasmsEndometrial NeoplasmsColorectal NeoplasmsSolid Carcinoma
- Interventions
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT06751329
- Locations
- πΊπΈ
The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
π¦πΊCancer Care Wollongong, Wollongong, New South Wales, Australia
A Study of DM001 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungBreast NeoplasmsSolid Carcinoma
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT06475937
- Locations
- πΊπΈ
Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States
π¦πΊIcon Cancer Centre South Brisbane, South Brisbane, Queensland, Australia
π¦πΊTasman Oncology Research, Southport, Queensland, Australia
Β© Copyright 2025. All Rights Reserved by MedPath